During the past decade, Cardioangiologisches Centrum Bethanien conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 7 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardioangiologisches Centrum Bethanien" #1 sponsor was "Abbott Medical Devices" with 6 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 5 trials sponsored, "Boston Scientific Corporation" with 4 trials sponsored, "Cardioangiologisches Centrum Bethanien" with 4 trials sponsored and "Stiftung Institut fuer Herzinfarktforschung" with 4 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardioangiologisches Centrum Bethanien" #1 collaborator was "Medtronic" with 3 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator, "CRO Kottmann" with 1 trials as a collaborator, "Clinical Research Services, Mannheim, Germany" with 1 trials as a collaborator and "Deutsches Herzzentrum Muenchen" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Cardioangiologisches Centrum Bethanien" are "Atrial Fibrillation" (11 trials), "Stroke" (5 trials), "Heart Failure" (2 trials), "Peripheral Arterial Disease" (2 trials) and "Persistent Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Cardioangiologisches Centrum Bethanien" in a lesser frequency.

Most popular intervention types in "Cardioangiologisches Centrum Bethanien" are "Device" (18 trials), "Drug" (3 trials), "Other" (3 trials), "Procedure" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "WATCHMAN Left Atrial Appendage Closure" (2 trials), "AMPLATZER™ LAA Occluder" (1 trials), "Amulet Left Atrial Appendage Occluder" (1 trials), "Antiarrhythmic Drugs" (1 trials) and "Blood sampling" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardioangiologisches Centrum Bethanien" are 32 trials for "All" genders.

Currently, there are NaN active trials in "Cardioangiologisches Centrum Bethanien". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Cardioangiologisches Centrum Bethanien, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardioangiologisches Centrum Bethanien, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 13 trials that are defined as “Not Applicable".

Cardioangiologisches Centrum Bethanien has several departments that took part in Clinical trials: "Cardioangiology Center Bethanien (CCB)" - 3 trials